We therefore applied a customized targeted sequencing approach for mutational hotspots of FGFR1, FGFR2, and FGFR3 and evaluated the effect of recombinant FGF2 on in vitro prednisolone sensitivity in BCP-ALL cell lines. Here, FGFR3 is linked to acute lymphoblastic leukemia.